Biokine Therapeutics Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Corporate
  • Investors
  • 6

Biokine Therapeutics General Information

Description

Developer of novel drugs designed to identifying novel molecular and cellular mechanisms that regulate tumor development and metastasis. The company's novel drugs offers cancer treatment, mainly leukemia and myeloma, enabling healthcare industries to develop novel therapeutics against these devastating diseases.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • Weizmann Science Park
  • PO Box: 2213
  • Rehovot 76120
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biokine Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Corporate 03-Oct-2018 Completed Generating Revenue
5. Merger/Acquisition 00000 Completed Generating Revenue
4. Grant 18-Mar-2009 00.00 00000 Completed Generating Revenue
3. Later Stage VC 10-Jan-2007 00000 00000 Completed Generating Revenue
2. Grant $600K Completed Startup
1. Accelerator/Incubator 01-Jul-2000 Completed Startup
To view Biokine Therapeutics’s complete valuation and funding history, request access »

Biokine Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Amnon Peled Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Orly Eizenberg Ph.D Co-Founder & Vice President, Research & Development
To view Biokine Therapeutics’s complete executive team members history, request access »

Biokine Therapeutics Board Members (6)

Name Representing Role Since
Amnon Peled Ph.D Biokine Therapeutics Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
Anthony Stanton Self Board Member 000 0000
H. Laurence Shaw MD Self Chairman 000 0000
Ofer Goldberg Clal Biotechnology Industries Board Member 000 0000
Shmuel Cabilly Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »